Okamura, Tomonori

写真a

Affiliation

School of Medicine, Department of Preventive Medicine and Public Health (Shinanomachi)

Position

Professor

Related Websites

External Links

Career 【 Display / hide

  • 1988.04

    Ministry of Health and Welfare, Japan

  • 1988.04
    -
    1993.03

    Kochi Prefectural Tosayamada Health Center

  • 1993.04
    -
    2000.02

    Osaka Medical Center for Cancer and Cardiovascular Diseases

  • 2000.03
    -
    2007.07

    Associate Professor, Department of Health Science, Shiga University of Medical Science

  • 2002.10
    -
    2003.08

    Department of Epidemiology and Public Health, Imperial College, London

display all >>

Academic Background 【 Display / hide

  • 1988.03

    University of Tsukuba, School of Medicine

    University, Graduated

Academic Degrees 【 Display / hide

  • MD,PhD, University of Tsukuba, Dissertation, 1996.02

Licenses and Qualifications 【 Display / hide

  • 医師免許, 1988.05

  • 日本医師会認定産業医, 1998.09

  • 中央労働災害防止協会 健康度測定研修修了医師, 1999.09

  • 介護支援専門員, 2001.03

  • 日本公衆衛生学会認定専門家, 2011.03

display all >>

 

Research Areas 【 Display / hide

  • Life Science / Hygiene and public health (non-laboratory)

  • Preventive Medicine for cardiovascular disseases

Research Keywords 【 Display / hide

  • Preventive Medicine

  • Epidemiology and Public health

  • Dyslipidemia

  • Health Promotion

  • cardiovascular disease

display all >>

 

Books 【 Display / hide

  • 【よくわかる】高血圧と循環器病の予防と管理(第二版)

    岡村智教, (株)社会保険研究所, 2020

    Scope: 家族性高コレステロール血症・その他の原発性脂質異常症.,  Contact page: 274-275 Original author: 本高血圧学会,日本循環器病予防学会,日本動脈硬化学会,日本心臓病学会監修

  • [日本の循環器病とその危険因子の動向] 循環器病予防エビデンスブック

    岡村智教, 医歯薬出版株式会社 , 2020

    Scope: 血清コレステロール値と脂質異常症の動向,,  Contact page: 149-156 Original author: 日本循環器病予防学会監修

  • 第三期特定健診・特定保健指導ガイド(門脇 孝、津下一代 編)

    Okamura Tomonori, 南山堂、東京, 2018.09

    Scope: 冠動脈疾患(虚血性心疾患)発症予防からみた脂質管理.pp119-127

  • 岸玲子監修、小泉昭夫、馬場園明、今中雄一、武林亨編.NEW予防医学・公衆衛生学.

    Okamura Tomonori, 南江堂、東京, 2018

    Scope: 第2章.疫学と方法, pp64-80

  • 動脈硬化性疾患予防のための脂質異常症治療ガイド2018年版

    Okamura Tomonori, (社)日本動脈硬化学会、東京, 2018

display all >>

Papers 【 Display / hide

  • Small High-Density Lipoprotein and Omega-3 Fatty Acid Intake Differentiates Japanese and Japanese-Americans: The INTERLIPID Study.

    Okami Y, Chan Q, Miura K, Kadota A, Elliott P, Masaki K, Okayama A, Okuda N, Yoshita K, Miyagawa N, Okamura T, Sakata K, Saitoh S, Sakurai M, Nakagawa H, Stamler J, Ueshima H, INTERMAP and INTERLIPID Research Groups.

    Journal of atherosclerosis and thrombosis  2022.11

    ISSN  1340-3478

  • Association between visceral fat accumulation and decline in the estimated glomerular filtration rate based on cystatin C in the Japanese urban population: the KOBE study.

    Tanabe A, Hirata A, Kuwabara K, Kubo S, Higashiyama A, Hirata T, Sugiyama D, Nishida Y, Kubota Y, Kadota A, Nishikawa T, Miyamatsu N, Miyamoto Y, Okamura T

    Endocrine journal  2022.10

    ISSN  0918-8959

  • Impact of hypertension and diabetes on the onset of chronic kidney disease in a general Japanese population.

    Kaneyama A, Hirata A, Hirata T, Imai Y, Kuwabara K, Funamoto M, Sugiyama D, Okamura T

    Hypertension research : official journal of the Japanese Society of Hypertension (Hypertension Research)   2022.09

    ISSN  0916-9636

     View Summary

    Hypertension (HT) and diabetes mellitus (DM) are both major risk factors for chronic kidney disease (CKD); however, few studies have examined the impacts of the combination of HT and DM on CKD development in general populations. We aimed to explore whether HT or DM contributes more to CKD development in a Japanese community. A total of 5823 individuals without a history of CKD who underwent specific health checkups in fiscal year 2013 were monitored until the end of March 2018. Participants were categorized as having neither HT nor DM (none group), either HT or DM, and both (HT + DM). We calculated the hazard ratios (HRs) for developing CKD in each category using Cox proportional hazards models after adjusting for age, dyslipidemia, smoking, and alcohol drinking and with the none group as the reference. We also estimated the population attributable fraction (PAF) for CKD development in populations with either HT or DM or both. During a mean follow-up of 3.0 years, 759 individuals developed CKD, with HRs of 1.56 with a 95% confidence interval (CI) [1.33, 1.83], 1.22 with a 95% CI [0.86, 1.75], and 2.83 with a 95% CI [2.22, 3.63] for the HT only, DM only and HT + DM categories, respectively. Sex-specific analysis showed similar findings. The PAFs for CKD (14.1% and 17.2% for men and women, respectively) were the highest among participants with HT only. We concluded that in this Japanese community, HT contributed more than DM to CKD development; hence, managing hypertension is important to prevent CKD as well as diabetes.

  • Relationship between Serum Proprotein Convertase Subtilisin/Kexin Type 9 Concentration and Prevalence of Coronary Artery Calcium in a Community-Based Sample of Japanese Men.

    Kunimura A, Miura K, Segawa H, Torii S, Kondo K, Hisamatsu T, Kadota A, Fujiyoshi A, Yano Y, Nakagawa Y, Okamura T, Ueshima H, SESSA research group.

    Journal of atherosclerosis and thrombosis  2022.09

    ISSN  1340-3478

  • Reliable Information from Health Professionals Encourages Urban Japanese Mothers' Continued Participation in Health Checkups.

    Tsukinoki R, Murakami Y, Imamura H, Okamura T

    Healthcare (Basel, Switzerland) (Healthcare (Switzerland))  10 ( 8 )  2022.08

     View Summary

    We examined mothers’ health information sources and their relationships with continued participation in health checkups among urban Japanese mothers. Participants were 152 mothers below 40 years old with one or more children under 12 years old. We collected data at a children’s festival in Tokyo in 2019. A self-administered questionnaire was used to collect information regarding health checkups, trusted sources of information regarding mother’s health, and anthropological variables. Continued participation in health checkups was defined as participating in health checkups almost every year during the past five years. Logistic regression analysis was used to adjust for health insurance, mothers’ age, number of children, and current medical history. the sources of mothers’ health information trusted by over 20% of mothers in the two groups were “family”, “friends”, “Web/SNS”, and “healthcare professionals.” However, continued participation in health checkups was significantly associated with only the source of health information from “healthcare professionals” (odds ratio: 2.8 [95% confidence interval: 1.26–6.31], p = 0.01). These findings suggest that reliable information from health professionals encourages urban Japanese mothers’ continued participation in health checkups among Japanese mothers under 40 years old who have children under 12 years of age.

display all >>

Papers, etc., Registered in KOARA 【 Display / hide

display all >>

Reviews, Commentaries, etc. 【 Display / hide

  • Serum modified high-density lipoprotein and risk of atherosclerotic cardiovascular disease in a Japanese community-based nested case-control study

    Sata M., Kakino A., Hirata A., Iida M., Usami Y., Harada S., Fujita Y., Kohsaka S., Izawa Y., Sawano M., Oki K., Sugiyama D., Takahashi S., Takebayashi T., Sawamura T., Okamura T.

    European Journal of Preventive Cardiology (European Journal of Preventive Cardiology)  29 ( 5 ) E193 - E195 2022.03

    ISSN  20474873

  • Erratum: Development of a cardiovascular disease risk prediction model using the suita study, a population-based prospective cohort study in Japan (Journal of Atherosclerosis and Thrombosis, (2020) 27, 11, (1160-1175), 10.5551/jat.48843)

    Nakai M., Watanabe M., Kokubo Y., Nishimura K., Higashiyama A., Takegami M., Nakao Y.M., Okamura T., Miyamoto Y.

    Journal of Atherosclerosis and Thrombosis (Journal of Atherosclerosis and Thrombosis)  28 ( 3 )  2021

    ISSN  13403478

     View Summary

    Incorrect Since CVD risk increases with age, categories for age were based on 10-year intervals up to age 60 years and 5-year intervals thereafter. Diabetes mellitus (DM) is defined as having a fasting blood glucose level of ≥ 126 mg/dL, currently using anti-diabetic medication, or both. Cigarette smoking was dichotomized as current versus other. Low-density lipoprotein cholesterol (LDL-C) was calculated using the Friedewald equation . Non-HDL-C was calculated by subtracting HDL-C from TG. If the TG level was greater than 400 mg/dL, we set the value as missing (n =96). Correct Since CVD risk increases with age, categories for age were based on 10-year intervals up to age 60 years and 5-year intervals thereafter. Diabetes mellitus (DM) is defined as having a fasting blood glucose level of ≥ 126 mg/dL, currently using anti-diabetic medication, or both. Cigarette smoking was dichotomized as current versus other. Low-density lipoprotein cholesterol (LDL-C) was calculated using the Friedewald equation . Non-HDL-C was calculated by subtracting HDL-C from TC. If the TG level was greater than 400 mg/dL, we set the value as missing (n=96). 27) 27)

  • Guidelines on the clinical evaluation of medicinal products for treatment of dyslipidemia

    Yamashita S., Masuda D., Akishita M., Arai H., Asada Y., Dobashi K., Egashira K., Harada-Shiba M., Hirata K., Ishibashi S., Kajinami K., Kinoshita M., Kozaki K., Kuzuya M., Ogura M., Okamura T., Sato K., Shimano H., Tsukamoto K., Yokode M., Yokote K., Yoshida M.

    Journal of Atherosclerosis and Thrombosis (Journal of Atherosclerosis and Thrombosis)  27 ( 11 ) 1246 - 1254 2020

    ISSN  13403478

  • Statin intolerance clinical guide 2018

    Kajinami K., Tsukamoto K., Koba S., Inoue I., Yamakawa M., Suzuki S., Hamano T., Saito H., Saito Y., Masuda S., Nakayama T., Okamura T., Yamashita S., Kagawa T., Kaneyama J., Kuriyama A., Tanaka R., Hirata A.

    Journal of Atherosclerosis and Thrombosis (Journal of Atherosclerosis and Thrombosis)  27 ( 4 ) 375 - 396 2020

    ISSN  13403478

  • 日本における脂質と動脈硬化性疾患の関連-疫学研究のエビデンス-.

    平田匠、岡村智教.

    Medical Practice  36 ( 1 ) 40 - 44 2019

    Article, review, commentary, editorial, etc. (scientific journal), Joint Work

display all >>

Presentations 【 Display / hide

  • Clinical scores for atherosclerotic risk stratification in adults: strengths and limitations.

    Okamura T.

    WHF with National Member Session 7: International Atherosclerosis Society together with World Heart Federation. Japanese Circulation Society (JCS) together with World Congress of Cardiology (WCC) 2021. (Yokohama, Kanagawa) , 

    2021.03

    Symposium, workshop panel (nominated)

  • 脳卒中・循環器病対策基本法による循環器病予防のこれから.

    岡村智教.

    シンポジウム.第56回日本循環器病予防学会., 

    2020.12

    Symposium, workshop panel (nominated)

  • 脳卒中の早期受診・予防のための市民啓発の取り組み:地域介入の試み.

    岡村 智教.

    第 34 回日本神経救急学会学術集会., 

    2020.11

    Oral presentation (invited, special)

  • EPOCH-JAPAN(Evidence for Cardiovascular Prevention from Observational Cohorts in Japan)から見た循環器疾患死亡の生涯リスク.

    岡村智教.

    シンポジウム.第52回日本動脈硬化学会総会., 

    2020.07

    Symposium, workshop panel (nominated)

  • 脳卒中・循環器病の一次予防対策の現状と今後の課題.

    岡村智教.

    バイエル「心血管予防」スポンサードセミナー.第五回JCVA(日本心血管協会)学術集会, 

    2020.06

    Symposium, workshop panel (nominated)

display all >>

Research Projects of Competitive Funds, etc. 【 Display / hide

  • 変性リポ蛋白を含む脂質プロフィールと脳・心血管疾患の関連、その規定要因の解明(基盤研究A 21H04854)

    2021.04
    -
    Present

    日本学術振興会, Research grant, Principal investigator

  • 健康診査・保健指導における検診項目等の必要性、妥当性の検証、及び地域における検診実施体制の検討のための研究(厚生労働科学研究 19FA1008)

    2019.04
    -
    Present

    厚生労働省, 厚生労働科学研究費補助金, Research grant, Principal investigator

  • 生涯にわたる循環器疾患の個人リスクおよび集団のリスク評価ツールの開発を目的とした大規模コホート統合研究(厚生労働科学研究 H29-循環器等-一般-003)

    2017.04
    -
    2020.03

    厚生労働省, 厚生労働科学研究費補助金, Research grant, Principal investigator

  • 脂質異常症の質的な評価と動脈硬化性疾患の関連についての地域疫学研究(基盤研究B 16H05249)

    2016.04
    -
    2021.03

    日本学術振興会, Research grant, Principal investigator

  • 循環器疾患における集団間の健康格差の実態把握とその対策を目的とした大規模コホート共同研究(厚生労働科学研究 H26-循環器等(生習)-一般​-001)

    2014.04
    -
    2017.03

    厚生労働省, Research grant, Principal investigator

display all >>

Works 【 Display / hide

  • 生活習慣病予防のエビデンス(全24回)

    Okamura Tomonori

    2010.04
    -
    2012.03

    Other, Single

Awards 【 Display / hide

  • 日本動脈硬化学会五島雄一郎賞

    Okamura Tomonori, 2013.07, 日本動脈硬化学会, A series of community-based cohort studies concerning the relationship between dyslipidemia and cardiovascular disease in Japanese populations

    Type of Award: Award from Japanese society, conference, symposium, etc.

  • 日本疫学会奨励賞

    Okamura Tomonori, 2009.01, 日本疫学会, 日本人を対象とした脂質異常症の疫学研究

    Type of Award: Award from Japanese society, conference, symposium, etc.

  • 日本公衆衛生学会奨励賞

    Okamura Tomonori, 2002.10, 日本公衆衛生学会, 老人保健事業を中心とした地域保健対策の評価と推進に関する研究

    Type of Award: Award from Japanese society, conference, symposium, etc.

  • 厚生統計研究奨励賞

    Okamura Tomonori, 1998.12, 厚生統計協会, 循環器検診所見と高齢者(65~74歳)の生命予後、活動能力の関連についての追跡研究

    Type of Award: Award from publisher, newspaper, foundation, etc.

Other 【 Display / hide

  •  View Details

    先端医療センターコホート研究チーム チームリーダー

  •  View Details

    国立循環器病研究センター 客員部長

  •  View Details

    滋賀医科大学 客員教授

 

Courses Taught 【 Display / hide

  • PUBLIC HEALTH 2 (ADVANCED)

    2022

  • PUBLIC HEALTH 1 (BASIC)

    2022

  • PUBLIC HEALTH

    2022

  • PREVENTIVE MEDICINE AND PUBLIC HEALTH: SEMINAR

    2022

  • PREVENTIVE MEDICINE AND PUBLIC HEALTH: PRACTICE

    2022

display all >>

Courses Previously Taught 【 Display / hide

  • Public Health

    Keio University

    2018.04
    -
    2019.03

    Autumn Semester, Lecture, Within own faculty, 110people

  • 公衆衛生学

    Keio University

    2015.04
    -
    2016.03

    Autumn Semester, Lecture, Within own faculty

  • 公衆衛生学

    Keio University

    2014.04
    -
    2015.03

    Autumn Semester, Lecture, Within own faculty

  • 公衆衛生学

    Keio University

    2013.04
    -
    2014.03

    Autumn Semester, Lecture, Within own faculty

  • 公衆衛生学

    Keio University

    2012.04
    -
    2013.03

    Autumn Semester, Lecture, Within own faculty

display all >>

 

Social Activities 【 Display / hide

  • 全国健康保険協会 理事(保健担当)

    2017.10
    -
    Present
  • 健康保険組合連合会 データヘルス計画推進会議委員

    2014.05
    -
    2017.03

Memberships in Academic Societies 【 Display / hide

  • Japan Atherosclerosis Society

     
  • Japan Epidemiological Association

     
  • Japanese Medical Society of Alcohol and Drug Studies

     
  • The Japanese Association for Cerebro-cardiovascular Disease Control(JACD)

     
  • Japanese Society of Public Health, 

    2021.10
    -
    Present

display all >>

Committee Experiences 【 Display / hide

  • 2022.04
    -
    Present

    健康増進に係る科学的な知見を踏まえた技術的事項に関するワーキング・グループ主査, 厚生労働省

  • 2021.12
    -
    Present

    第4期特定健診・特定保健指導の見直しに関する検討会座長代理, 厚生労働省

  • 2021.10
    -
    Present

    健康管理システム等標準化検討会座長, 厚生労働省

  • 2020.04
    -
    Present

    健康・医療・介護情報利活用検討会 健診等情報利活用ワーキンググループ, 厚生労働省

  • 2015.02
    -
    Present

    厚生科学審議会臨時委員(地域保健健康増進栄養部会), 厚生労働省

display all >>